AERIE PHARMACEUTICALS INC Annual Income Tax Expense (Benefit) in USD from 2013 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2021.
  • Aerie Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $95K, a 63.8% increase year-over-year.
  • Aerie Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2022 was $1.32M, a 75.5% decline year-over-year.
  • Aerie Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was $593K, a 88.7% decline from 2020.
  • Aerie Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2020 was $5.25M.
  • Aerie Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2019 was -$90K, a 3100% decline from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $593K -$4.65M -88.7% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-25
2020 $5.25M +$5.34M Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 -$90K -$93K -3100% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $3K +$1.76M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$1.76M -$1.95M -1011% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $193K +$54K +38.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $139K +$139K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $0 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $0 Jan 1, 2013 Dec 31, 2013 10-K 2016-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.